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Abstract
Introduction: Advanced hemodynamic monitoring using transpulmonary thermodilution (TPTD) is established for
measurement of cardiac index (CI), global end-diastolic volume index (GEDVI) and extra-vascular lung water index
(EVLWI). TPTD requires indicator injection via a central venous catheter (usually placed via the jugular or subclavian
vein). However, superior vena cava access is often not feasible due to the clinical situation. This study investigates
the conformity of TPTD using femoral access.
Methods: This prospective study involved an 18-month trial at a medical intensive care unit at a university
hospital. Twenty-four patients with both a superior and an inferior vena cava catheter at the same time were
enrolled in the study.
Results: TPTD-variables were calculated from TPTD curves after injection of the indicator bolus via jugular access
(TPTDjug) and femoral access (TPTDfem). GEDVIfem and GEDVIjug were significantly correlated (rm = 0.88; P <
0.001), but significantly different (1,034 ± 275 vs. 793 ± 180 mL/m
2; P < 0.001). Bland-Altman analysis demonstrated
a bias of +241 mL/m
2 (limits of agreement: -9 and +491 mL/m
2). GEDVIfem, CIfem and ideal body weight were
independently associated with the bias (GEDVIfem-GEDVIjug). A correction formula of GEDVIjug after femoral TPTD,
was calculated. EVLWIfem and EVLWIjug were significantly correlated (rm = 0.93; P < 0.001). Bland-Altman analysis
revealed a bias of +0.83 mL/kg (limits of agreement: -2.61 and +4.28 mL/kg). Furthermore, CIfem and CIjug were
significantly correlated (rm = 0.95; P < 0.001). Bland-Altman analysis demonstrated a bias of +0.29 L/min/m
2 (limits
of agreement -0.40 and +0.97 L/min/m
2; percentage-error 16%).
Conclusions: TPTD after femoral injection of the thermo-bolus provides precise data on GEDVI with a high
correlation, but a self-evident significant bias related to the augmented TPTD-volume. After correction of GEDVIfem
using a correction formula, GEDVIfem shows high predictive capabilities for GEDVIjug. Regarding CI and EVLWI,
accurate TPTD-data is obtained using femoral access.
Introduction
Advanced hemodynamic monitoring is a cornerstone of
intensive care. Transpulmonary thermodilution (TPTD)
is established for the measurement of cardiac index (CI),
preload, volume responsiveness and pulmonary hydra-
tion in critically ill intensive care unit (ICU) patients
[1-9]. For the assessment of volume responsiveness
TPTD provides volumetric parameters such as global
end-diastolic volume index (GEDVI) that can be used
regardless of sinus rhythm and controlled ventilation
[2,4-6].
In addition, TPTD accurately allows measurement of
extra-vascular lung water index (EVLWI) to quantify the
degree of pulmonary edema [8,10-21]. TPTD is based
on the injection of a cold saline bolus through a central
venous catheter (CVC) in the central venous circulation.
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u pb yat h e r m i s t o rl o c a t e di nt h et i po fac a t h e t e r
usually placed in the descending aorta through the
femoral artery. A thermodilution curve is created and
the hemodynamic parameters are obtained after its ana-
lysis. CI, GEDVI and EVLWI are calculated using three
main values determined by contour analysis of the ther-
modilution curve: area under the curve, mean transit
time, and down-slope time. Mean transit time describes
the time until half of the injected saline bolus has
passed the thermistor. Down-slope time describes the
duration of the exponential decrease of the dilution
curve and allows calculation of the largest of several ser-
ies-connected chambers and finally of EVLWI.
Usually the CVC for TPTD is placed via the jugular or
subclavian vein. Superior vena cava access was a prere-
quisite in the validation studies for TPTD. However,
superior vena cava access is often not feasible due to
the clinical situation. Clinical circumstances such as
thrombosis of the jugular vein, polytrauma, burns, use
of the superior vena cava access for Shaldon catheters
and infection of previous puncture sites might necessi-
tate femoral access. In these situations the CVC has to
be inserted in the inferior vena cava via the femoral
vein. Moreover, femoral venous catheterization provides
a rapid way in emergency situations to obtain central
venous vascular access. A review of the literature clearly
demonstrates that the use of femoral vein access for
central venous access is often necessary. In recent stu-
dies investigating the influence of the insertion site on
CVC colonisation and bloodstream infections femoral
access was used in about 20 to 35% of all catheter inser-
tions [22,23].
To the best of our knowledge, only one report on 11
patients with different numbers of measurements per
patient investigated the accuracy of TPTD variables
derived after central venous injection via the femoral
access [24].
Therefore, it was the aim of our study to prospectively
investigate the conformity of femoral versus jugular
access TPTD in 24 critically ill patients with an identical
number of two pairs of TPTD measurements in each
patient.
Materials and methods
Patients
Between January 2008 and June 2009, 24 patients trea-
ted in the medical ICU of a German university hospital
(Klinikum rechts der Isar der Technischen Universität
München, Munich, Germany) were included in the
study. All patients had both a superior and an inferior
vena cava catheter at the same time for clinical reasons
unrelated to the study. A total of 96 TPTD measure-
ments were analyzed (48 TPTDs via femoral access
compared to 48 TPTDs via jugular access; four TPTDs
per patient, two TPTDs per patient via femoral venous
access and two TPTDs per patient via jugular venous
access). Each TPTD measurement represents the mean
of three consecutive TPTD indicator injections. Between
June 2009 and October 2009, five more patients were
separately studied to evaluate the correction formula for
GEDVI derived from the first 24 patients in a different
s t u d yp o p u l a t i o n .T h e s ef i v ep a t i e n t sw e r en o ti n c l u d e d
i nt h ep r i m a r ys t u d ya n a l y s i sb u ts e r v e da sac o n t r o l
group. In these five patients a total of 20 TPTD mea-
surements were analyzed (10 TPTDs via femoral access
compared to 10 TPTDs via jugular access; four TPTDs
per patient, two TPTDs per patient via femoral venous
access and two TPTDs per patient via jugular venous
access). The study was approved by the local ethics
committee (Technical University of Munich, project
number 2074/08). Informed consent was obtained
according to the Declaration of Helsinki.
TPTD measurements
TPTD was performed using a 5-French thermistor-
tipped arterial line (Pulsiocath, Pulsion Medical Systems
AG, Munich, Germany) that was inserted in the abdom-
inal aorta through the femoral artery and connected to
a hemodynamic monitor (PiCCO-Plus, software version
7.1; PiCCO-2, software version 1.3.0.8; Pulsion Medical
Systems AG). Using the superior vena cava catheter and
the inferior vena cava catheter, respectively, central
venous pressure (CVP) was recorded throughout the
respiratory cycle and measured at end-expiration. In all
patients the same type of 4-lumen CVC was used for
femoral and jugular access (MultiCath 4 Expert, 8.5
French; Vygon GmbH & Co. KG, Aachen, Germany).
After insertion of the catheter the correct tip position of
the jugular CVC was verified by x-ray. Femoral CVCs
were completely inserted. According to the manufac-
turer’s recommendation, via the jugular and femoral
access, respectively, 15 mL cold saline 0.9% were
injected through the distal lumen of the catheter (prim-
ing lumen of the distal catheter lumen: 0.38 mL). Based
on TPTD, CI, GEDVI and EVLWI were determined
[8,9,20,25-27]. Each PiCCO measurement represents the
mean of three consecutive thermodilution measure-
ments. Measurement procedures were performed twice
for each patient with a mean time interval of 9.54 ±
7.27 hours (minimum one hour, maximum 24 hours).
One measurement procedure consisted of three injec-
tions via jugular vein and three injections via femoral
vein within a maximum of 15 minutes. During the mea-
surement procedures no changes were made in catecho-
lamine therapy or intravascular volume administration,
respirator settings and the patients’ position. The CVC
site for the initial injection (jugular or femoral vein) was
Saugel et al. Critical Care 2010, 14:R95
http://ccforum.com/content/14/3/R95
Page 2 of 10selected randomly. Hemodynamic parameters, deter-
mined using TPTD via superior vena cava access, were
compared with those derived from TPTD via inferior
vena cava access. Global end-diastolic volume (GEDV)
was indexed for body surface area and extra-vascular
lung water (EVLW) was indexed for predicted body
weight.
Statistical analysis
Bivariate correlation of quantitative data (means of
paired measurements per patient) was assessed using
Spearman correlation coefficient (rm).
Normality of data was assessed both, descriptively (by
investigating histograms and QQ-plots) and by using
statistical tests (Shaphiro-Wilk test). There were no con-
siderable violations of normality. Since Spearman rank
correlation describes the monotonicity of bivariate rela-
tionship and is not sensitive to high leverage points this
measure was preferred to the ordinary linear correlation
coefficient.
With a total number of 24 patients modest bivariate
correlations of about |r| (absolute amount of r) = 0.50
or higher would have been detectable with 80% power
at a two sided level of significance of 5%.
The percentage errors of hemodynamic parameters
were calculated as demonstrated by Critchley [28].
The root mean square coefficient of variation
(RMSCV) was determined to assess variability of
repeated single TPTD measurements. Since RMSCV is
independent of the level of measurement it provides an
appropriate quantity for a comparative evaluation of
measurement stability.
To illustrate differences of TPTD parameters derived
after femoral and jugular injection in dependence of
mean measurement levels Bland-Altman-plots were pro-
vided. In this term, agreement between two measure-
ment methods was evaluated by calculating the
systematically error (bias) with the 95% limits of indivi-
dual agreement as bias ± 2 standard deviation (SD).
Random effects models were used to estimate the
within-subject variation and to achieve estimates of total
variability for Bland-Altman analysis considering the
issue of repeated measures per subject [29].
By the use of multiple linear regression analysis, pre-
diction models for jugular TPTD parameters were devel-
oped. For this purpose, potentially predictive capability
of femoral parameters was assessed by a general estima-
tion equation (GEE) model [30]. The GEE approach
properly reflects the structure of repeated data and
takes correlation of repeated (two pairs of) measure-
ments per patient into account. No consideration of
repeated data issue would yield to overly optimistic esti-
mates (smaller standard errors) and therefore potentially
to inappropriate conclusions.
Parameters which showed a substantial linear correla-
tion (indicated by a P-value for the regression coefficient
<0.10 and leading to an elevated adjusted r
2, respec-
tively) within the multivariable GEE model, were consid-
ered in the final prediction model based on means of
paired measurements per patient.
Means were reported with standard deviations (mean
± SD) and regression coefficients (slopes) from linear
GEE models were depicted with standard errors (b ±
SE). Statistical analysis was performed using software
(SPSS. version 16; SPSS inc., Chicago, IL, USA).
Results
Patients and patients’ characteristics
A total of 96 TPTDs (48 via femoral access, 48 via jugu-
lar access) of 24 critically ill ICU patients were enrolled
in this study. Basic demographic data and reasons for
ICU admission are shown in Table 1.
TPTD, vascular access
TPTD variables were calculated from TPTD curves after
jugular injection (TPTD variable jug) and femoral injec-
tion (TPTD variable fem).
Basic cardiopulmonary characteristics, variability of
single TPTD measurements (root mean square coeffi-
cient of variation) and data concerning site of vascular
access are depicted in Table 1.
Effect of catheter site on TPTD measurements
GEDVIfem and GEDVIjug were highly significantly cor-
related (rm = 0.88; b = 1.32 ± 0.11, P < 0.001), but their
means were significantly different (1,034 ± 275 vs. 793 ±
180 mL/m
2; P < 0.001) (Figure 1a). Bland-Altman analy-
sis resulted in a bias of +241 mL/m
2 and limits of agree-
ment of -9 and +491 mL/m
2 (Figure 2a, Table 2).
Comparison of the two pairs of measurements in each
patient demonstrated a significant intra-individual corre-
lation of the differences (GEDVIfem-GEDVIjug) (r =
0.79; P < 0.001) (Figure 3).
We performed GEE-regression analyses to characterize
the main factors significantly associated with the differ-
ence (GEDVIfem-GEDVIjug).
Bivariate correlation analyses suggested an association
o ft h ed i f f e r e n c e( G E D V I f e m - G E D V I j u g )w i t hh e i g h t
(rm = 0.32; b = 4.8 ± 2.2, P = 0.031), normal body weight
(BW) (rm = 0.32; b = 4.8 ± 2.2, P = 0.031), GEDVIfem
(rm = 0.87; b = 0.42 ± 0.05, P < 0.001) and GEDVIjug
(rm = 0.58; b = 0.32 ± 0.11, P = 0.005). Furthermore, co-
linearity of height and BW was demonstrated with ideal
BW (IBW) as the parameter with the strongest associa-
tion to the difference (GEDVIfem-GEDVIjug). Therefore,
GEDVIfem, CIfem and IBW were included in generalized
linear models to characterize factors independently asso-
ciated with the difference (GEDVIfem-GEDVIjug). The
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Page 3 of 10final model including GEDVIfem (P <0 . 0 0 1 ) ,C I f e m( P =
0.011) and IBW (P =0 . 1 6 2 )r e s u l t e di nt h ep r e d i c t i o n
formula of GEDVIjug with the highest predictive capabil-
ity (adjusted r
2 = 0.75) (Figure 4):
GEDVIjug (mL / m ) 0.539* GEDVIfem 15.17
 24.49* CIfem 2.311* I
2 =−
++ B BW
(GEDVIjug, jugular global end-diastolic volume index
(mL/m
2); GEDVIfem, femoral global end-diastolic
volume index (mL/m
2); CIfem, femoral cardiac index
(L/min/m
2); IBW, ideal body weight (kg)).
We calculated sensitivity, specificity, positive predictive
value (PPV), negative predictive value (NPV) and accu-
racy for prediction of elevated GEDVIjug (>800 mL/m
2)
and decreased GEDVIjug (<680 mL/m
2) based on uncor-
rected GEDVIfem, GEDVIfem corrected by subtraction
o ft h em e a nb i a so f+ 2 4 1m L / m
2 as well as GEDVIfem
corrected by the correction formula (Table 3). Although
even uncorrected GEDVIfem resulted in acceptable pre-
dictive capabilities, correction resulted in further
improvement of the prediction of GEDVIjug.
To evaluate the usefulness of the correction formula
derived from the first 24 patients following the study period
we studied five more consecutive patients with superior
and inferior vena cava access at the same time as a control
population (four males, one female; mean age 57.2 ± 9.0
years, mean height 178 ± 13 cm, mean weight 93.6 ± 20.2
kg; two patients died on ICU, three patients survived ICU
stay, reason for ICU admission: pancreatitis in two patients,
cirrhosis of the liver in two patients, pneumonia in one
patient). Mean GEDVIfem and GEDVIjug in these patients
was 896 ± 126 mL/m
2 and 720 ± 76 mL/m
2, respectively.
The mean difference between GEDVIfem and GEDVIjug
(bias) in this control group was 20% of GEDVIfem
(176 mL/m
2). In this group correction of GEDVIfem by
subtraction of the mean bias of +241 mL/m
2 (mean bias in
Table 1 Patients’ characteristics, cardiopulmonary
characteristics, reason for intensive care unit admission
and vascular access
Mean ± SD Range
Patients’ characteristics
Sex, n 15 men, 9
women
Age, years 67.4 ± 9.5 46 to 88
Height, cm 171 ± 8 156 to 187
Weight, kg 75.3 ± 18.5 45.0 to 110.0
Body surface area, m
2 1.87 ± 0.27 1.40 to 2.40
Body mass index, kg/m
2 25.5 ± 4.8 16.5 to 35.9
Ideal body weight, kg 62.8 ± 8.5 47.6 to 78.3
Normal body weight, kg 71.0 ± 8.1 56.0 to 87.0
Predicted body weight, kg 65.6 ± 9.3 48.8 to 81,5
Adjusted body weight, kg 69.1 ± 11.9 49.3 to 91.7
SAPS II 41.3 ± 10.9 26 to 66
TISS 20.8 ± 6.1 9 to 34
ICU survival, n 11 yes, 13 no
Cardiopulmonary characteristics
Heart rate, beats per minute 93.8 ± 16.7 61 to 125
Mean arterial pressure, mmHg 85.5 ± 15.0 60 to 122
CIjug-avg, L/min/m
2 4.03 ± 1.13 2.30 to 7.30
CIfem-avg, L/min/m
2 4.31 ± 1.18 2.41 to 7.45
GEDVIjug-avg, mL/m
2 793 ± 180 497 to 1,213
GEDVIfem-avg, mL/m
2 1,034 ± 275 599 to 1,646
EVLWIjug-avg, mL/kg 10.71 ± 3.43 4 to 18
EVLWIfem-avg, mL/kg 11.54 ± 3.89 4 to 20
RMSCV CIjug 0.06
RMSCV CIfem 0.05
RMSCV GEDVIjug 0.06
RMSCV GEDVIfem 0.05
RMSCV EVLWIjug 0.06
RMSCV EVLWIfem 0.07
CVPjug-avg, mmHg 16.1 ± 5.4 4 to 27
CVPfem-avg, mmHg 17.7 ± 5.7 6 to 34
Sinus rhythm, n 22 (92%)
Atrial fibrillation, n 2 (8%)
Mechanical ventilation, n 18 (75%)
Catecholamine therapy, n 16 (67%)
Sinus rhythm + controlled ventilation 8 (33%)
Reason for ICU admission
Pneumonia, acute respiratory
insufficiency, n
7 (29%)
cirrhosis of the liver/liver failure, n 6 (25%)
gastrointestinal bleeding, n 4 (17%)
need for cardiopulmonary
resuscitation, n
3 (13%)
sepsis, n 2 (8%)
pancreatitis, n 2 (8%)
Vascular access
arterial line right femoral artery, n 13 (54%)
arterial line left femoral artery, n 11 (46%)
CVC right jugular vein, n 14 (58%)
Table 1 Patients’ characteristics, cardiopulmonary
characteristics, reason for intensive care unit admission
and vascular access (Continued)
CVC left jugular vein, n 10 (42%)
CVC right femoral vein, n 16 (67%)
CVC left femoral vein, n 8 (33%)
CVC and arterial line on same side 14 (58%)
CVC and arterial line on different
sides
10 (42%)
SAPS II, Simplified Acute Physiology Score; TISS, Therapeutic Intervention
Scoring System; CIjug-avg, average of jugular cardiac index; CIfem-avg,
average of femoral cardiac index; GEDVIjug-avg, average of jugular global
end-diastolic volume index; GEDVIfem-avg, average of femoral global end-
diastolic volume index; EVLWIjug-avg, average of jugular extra-vascular lung
water index; EVLWIfem-avg, average of femoral extra-vascular lung water
index; RMSCV, root mean square coefficient of variation; CVPjug-avg, average
of jugular central venous pressure; CVPfem-avg, average of femoral central
venous pressure; CVC, central venous catheter.
Saugel et al. Critical Care 2010, 14:R95
http://ccforum.com/content/14/3/R95
Page 4 of 10Figure 2 Transpulmonary thermodilution after femoral and
jugular injection: Bland-Altman analysis. Bland-Altman analysis of
global end-diastolic volume index (a), extra-vascular lung water
index (b) and cardiac index (c) derived from transpulmonary
thermodilution after femoral and jugular injection. GEDVIjug, jugular
global end-diastolic volume index (mL/m
2); GEDVIfem, femoral
global end-diastolic volume index (mL/m
2); EVLWIjug, jugular extra-
vascular lung water index (mL/kg); EVLWIfem, femoral extra-vascular
lung water index (mL/kg); CIjug, jugular cardiac index (L/min/m
2);
CIfem, femoral cardiac index (L/min/m
2). The solid line indicates the
mean difference between variables determined after femoral and
jugular injection. The dotted lines indicate the limits of agreement
(2*SD).
Figure 1 Correlation of femoral and jugular transpulmonary
thermodilution variables. Scatter plot showing the correlation of
femoral and jugular global end-diastolic volume index (rm = 0.88;
P < 0.001) (a), femoral and jugular extra-vascular lung water index
(rm = 0.93; P < 0.001) (b), and femoral and jugular cardiac index
(rm = 0.95; P < 0.001) (c). GEDVIjug, jugular global end-diastolic
volume index (mL/m
2); GEDVIfem, femoral global end-diastolic
volume index (mL/m
2); EVLWIjug, jugular extra-vascular lung water
index (mL/kg); EVLWIfem, femoral extra-vascular lung water index
(mL/kg); CIjug, jugular cardiac index (L/min/m
2); CIfem, femoral
cardiac index (L/min/m
2).
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ence to 7% (65 mL/m
2). A further reduction of the bias to
6% (50 mL/m
2) was achieved using the correction formula.
Uncorrected GEDVIfem had a diagnostic accuracy for pre-
diction of elevated GEDVIjug (>800 mL/m
2) and decreased
GEDVIjug (<680 mL/m
2)o fo n l y2 0 % .C o r r e c t i o no fG E D -
VIfem by subtraction of the mean bias of +241 mL/m
2
resulted in an accuracy of 60%. However, a diagnostic accu-
racy of 70% in this control population could be achieved
when GEDVIfem was corrected by the correction formula.
The comparison of EVLWIfem and EVLWIjug
demonstrated that EVLWIfem and EVLWIjug were
highly significantly correlated (rm =0 . 9 3 ;b=1 . 0 7±
0.05, P < 0.001), but significantly different (11.54 ± 3.89
vs. 10.71 ± 3.43 mL/kg; P < 0.001) (Figure 1b).
In Figure 2b and Table 2 Bland-Altman analysis for
the comparison of EVLWIfem and EVLWIjug is
depicted (bias +0.83 mL/kg; limits of agreement -2.61
and +4.28 mL/kg).
Bivariate correlation analyses suggested an association
of the difference (EVLWIfem-EVLWIjug) with EVLWI-
fem (rm = 0.50; b = 0.19 ± 0.04, P <0 . 0 0 1 )a n dC I f e m
(rm = -0.46; b = -0.25 ± 0.10, P = 0.015).
Regarding a co-linearity of height and adjusted BW,
the final generalized model included adjusted BW, EVL-
WIfem and CIfem to characterize factors independently
associated with the difference (EVLWIfem-EVLWIjug).
Including the independently predictive factors EVLWI-
fem (P <0 . 0 0 1 )a n dC I f e m( P =0 . 0 1 4 )t h a tw e r ea s s o c i a t e d
with the difference (EVLWIfem-EVLWIjug) resulted in a
prediction formula of EVLWIjug (adjusted r
2 = 0.34):
EVLWIjug (mL / kg) 0.863* EVLWIfem
 0.88 0.377*CIfem
=
−+
(EVLWIjug, jugular extra-vascular lung water index
(mL/kg); EVLWIfem, femoral extra-vascular lung water
index (mL/kg); CIfem, femoral cardiac index (L/min/m
2)).
CI was calculated after femoral injection (CIfem) and
jugular injection (CIjug). Figure 1c shows that CIfem
and CIjug were significantly different (4.31 ± 1.18 vs.
Table 2 Bias and 95% limits of agreement of variables derived from femoral and jugular transpulmonary
thermodilution
TPTD fem vs. jug Bias 95% limits of agreement Percentage error
GEDVIfem vs. GEDVIjug +241 mL/m
2 -9 mL/m
2
+491 mL/m
2
-
EVLWIfem vs. EVLWIjug +0.83 mL/kg -2.61 mL/kg
+4.28 mL/kg
-
CIfem vs. CIjug +0.29 L/min/m
2 -0.40 L/min/m
2
+0.97 L/min/m
2
16%
TPTD, transpulmonary thermodilution; GEDVIfem, femoral global end-diastolic volume index; GEDVIjug, jugular global end-diastolic volume index; EVLWIfem,
femoral extra-vascular lung water index; EVLWIjug, jugular extra-vascular lung water index; CIfem, femoral cardiac index; CIjug, jugular cardiac index.
Figure 3 Intra-individual correlation of the two pairs of
transpulmonary thermodilution measurements. Scatter plot
demonstrating significant intra-individual correlation of the two
pairs of transpulmonary thermodilution measurements (No. 1 and
No. 2) in each patient (r = 0.79; P < 0.001). GEDVIjug, jugular global
end-diastolic volume index (mL/m
2); GEDVIfem, femoral global end-
diastolic volume index (mL/m
2); GEDVIfem - GEDVIjug, difference
between GEDVI values after femoral and jugular injection; TPTD,
transpulmonary thermodilution.
Figure 4 Femoral global end-diastolic volume index corrected
by the correction formula. Scatter plot illustrating the predictive
capability of the correction formula of jugular global end-diastolic
volume index (adjusted r
2 = 0.75). GEDVIjug, jugular global end-
diastolic volume index (mL/m
2).
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2; P < 0.001) but highly significantly
correlated (rm = 0.95; b = 0.99 ± 0.04, P < 0.001).
Bland-Altman analysis revealed a bias of +0.29 L/min/
m
2 with lower/upper limit of agreement of -0.40 and
+0.97 L/min/m
2 ( F i g u r e2 c ,T a b l e2 ) .T h ep e r c e n t a g e
error was 16%. The final prediction model for CIjug
based on GEDVIfem (P <0 . 0 0 1 )a n dC V P f e m( P =
0.004) demonstrated a substantial fit (adjusted r
2 = 0.49)
with the correction formula:
CIjug (L / min / m ) 0.931*CIfem 1.45 0.00042*GEDVIfem
0.028*C
2 =+ −
+ V VPfem 0.009* height −
(CIjug, jugular cardiac index (L/min/m
2); CIfem,
femoral cardiac index (L/min/m
2); GEDVIfem, femoral
global end-diastolic volume index (mL/m
2); CVPfem,
femoral central venous pressure (mmHg); height (cm)).
Discussion
Regarding the importance of GEDVI, EVLWI and CI we
investigated the accuracy of TPTD measurements using
femoral injection of the TPTD bolus instead of the gold
standard injection sites via superior vena cava access.
We found a highly significant correlation of GEDVI,
EVLWI and CI determined after femoral injection com-
pared to simultaneous measurements via jugular access.
The bias for EVLWI and CI was low (with a low per-
centage error for CI). Uncorrected EVLWIfem and
CIfem had high predictive capabilities for the normal
ranges as well as for pathological values of EVLWIjug
and CIjug. Using correction formulas derived from our
data further improved the predictive capabilities.
Regarding GEDVI, a significant and self-explaining
bias was expected according to the principle of GEDVI
determination. GEDVI is calculated as 0.8*(ITTV -
EVLWI) with ITTV (intrathoracic thermal volume)
being the total volume participating in indicator dilution
between the tip of the venous injection site and the tip
of the arterial TPTD detection site. Injection of the indi-
cator in the distal inferior vena cava adds the volume of
the inferior vena cava to the total volume participating
in thermodilution, resulting in an artificial increase in
mean transit time and ITTV.
Therefore it was a further aim of our study to develop
a correction formula of GEDVIjug compensating GED-
VIfem for the bias (GEDVIfem-GEDVIjug) and factors
independently associated with the bias.
Simple subtraction of the mean bias of +241 mL/m
2
from GEDVIfem resulted in high sensitivity, specificity,
PPV, NPV and accuracy regarding decreased as well as
increased GEDVIjug. Correction of GEDVIfem using the
correction formula resulted in even higher predictive cap-
abilities, emphasizing a certain robustness of the formula
in the study population as well as in the group of the five
more consecutive patients studied as a control population.
Interestingly, the mean difference of GEDVIfem and
GEDVIjug was about 100 mL higher than in the study of
Schmidt et al. [24]. However, the number of patients in
this study was not high and there were multiple measure-
ments (one to nine per patients) included in the results.
Therefore, it can not be excluded that the bias in this
study was influenced by multiple measurements in a
patient with a smaller difference of (GEDVIfem-GEDVI-
jug). Regarding the additional volume of parts of the infer-
ior vena cava participating in TPTD, this also could be
related to the different height of the patient population as
well as to the different preload conditions. Despite no
access to the original data of Schmidt et al., calculation of
mean GEDVIfem, mean CIfem and extrapolation of the
ideal body weight (based on mean height and three female
and eight male patients included in this study) and using
these mean data in our formula would have estimated
GEDVIjug 792.65 mL instead of 876.85 mL with a mean
bias of 84.2 mL. This is a reduction of 56.5 mL or 40%
Table 3 Predictive capabilities of uncorrected and corrected femoral global end-diastolic volume index
Uncorrected GEDVIfem GEDVIfem - mean bias
(GEDVIfem - GEDVIjug)
GEDVIfem corrected by the
correction formula
Diagnostic accuracy 67% 90% 88%
Sensitivity elevated GEDVIjug 100 100 100
Specificity elevated GEDVIjug 61 91 96
PPV elevated GEDVIjug 74 93 96
NPV elevated GEDVIjug 100 100 100
Sensitivity decreased GEDVIjug 31 100 81
Specificity decreased GEDVIjug 100 91 94
PPV decreased GEDVIjug 100 84 87
NPV decreased GEDVIjug 74 100 91
Diagnostic accuracy, sensitivity, specificity, positive predictive value, negative predictive value for the prediction of jugular global end-diastolic volume based on
uncorrected femoral global end-diastolic volume index, femoral global end-diastolic volume index corrected by subtraction of the mean bias and femoral global
end-diastolic volume index corrected by the correction formula.
GEDVIfem, femoral global end-diastolic volume index; GEDVIjug, jugular global end-diastolic volume index; PPV, positive predictive value; NPV, negative
predictive value. Elevated GEDVI means GEDVI >800 mL/m
2 and decreased GEDVI means GEDVI <680 mL/m
2
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VIfem, thus suggesting a certain usefulness of the formula
in different patient populations.
Regarding EVLWI we found even better bias, accu-
racy and other predictive capabilities of EVLWIfem
with respect to EVLWIjug. Regarding theoretical con-
siderations with EVLWI based on the downslope time
of the thermodilution curve this finding is not surpris-
ing. The downslope time, a linear part of the thermo-
dilution curve, is determined by the largest
compartment of the different series-connected com-
partments participating in the dilution of the TPTD
indicator bolus. Since the volume of this compartment
(pulmonary thermovolume, PTV) comprising EVLW
and pulmonary blood volume (PBV) theoretically is
not influenced by the addition of a further compart-
ment (inferior vena cava) between the injection site
(inferior vena cava) and the right atrium, the bias
should be close to zero. Considering the calculation of
EVLW based on subtraction of PBV from PTV esti-
mating PBV 25% of GEDV, a small systematic bias of
uncertain clinical relevance could be postulated. How-
ever, despite a small but significant difference of EVL-
WIjug and EVLWIfem, considering high predictive
capabilities of EVLWIjug using EVLWIfem, this small
difference seems to be without clinical relevance.
Similar considerations apply for the comparison of
CIfem and CIjug. Uncorrected CIfem showed high pre-
dictive capabilities for CIjug. A small bias of 0.29 L/
min/m
2 and a percentage error as low as 16% show that
uncorrected CIfem can be used for the assessment of
cardiac output in the setting of critically ill ICU patients.
The small bias and the low percentage error are in line
with theoretical considerations that the area under the
curve of the thermodilution curve determining CI
should not substantially be affected by injection of the
indicator in the femoral vein.
These findings seem to be of importance in daily clini-
cal practice since CVC insertion via superior vena cava
access is not feasible in several critically ill patients who
need to be monitored using advanced hemodynamic
monitoring: Thrombosis of jugular or subclavian veins or
use of these veins for dialysis catheters can make it
impossible to use superior vena cava access for CVC pla-
cement. Furthermore, for emergency central venous
access and in burn patients as well as patients with con-
traindication for Trendelenburg position (neurologic/
neurosurgery patients, heart insufficiency), CVC insertion
via the femoral vein can be of special importance [31,32].
Limitations of the study
Despite a higher number of patients included and pro-
viding a constant number of measurements in each
patient compared to previous data, our study was
performed in a limited number of patients in the study
population. The study was performed monocentric in a
medical ICU. Moreover, the number of patients in the
control population is small. Furthermore, our study
population contained only one patient with severe obe-
sity (BMI >35 kg/m
2) and one patient with underweight
(BMI <18.5 kg/m
2).
Despite encouraging application to our control collec-
tive and to previous data, the correction formulas in
particular have to be confirmed in future investigations
of different patient populations and in multicentric
studies.
Conclusions
TPTD after injection of the thermo-bolus through a
femoral CVC provides precise data on GEDVI with a
high correlation but a self-evident significant bias related
to the augmented TPTD-volume. After correction of
GEDVIfem using a correction formula, GEDVIfem
shows high predictive capabilities for GEDVIjug.
R e g a r d i n gC Ia n dE V L W Ia c c u r a t eT P T D - d a t ai s
obtained using femoral access.
These data seem to be of importance regarding an
underestimated frequency of femoral central venous
access, particularly in emergency situations, malfunction
of variability parameters (such as stroke volume varia-
tion (SVV)) in numerous patients requiring hemo-
dynamic monitoring devoid of sinus rhythm and
controlled ventilation, and numerous studies emphasiz-
ing the clinical usefulness of volumetric parameters such
as GEDVI and EVLWI.
Key messages
￿ TPTD after injection of the indicator bolus via a
femoral central venous catheter provides precise
data on GEDVI with a high correlation but signifi-
cant bias related to the augmented thermodilution
volume.
￿ A correction formula for jugular GEDVI after
femoral TPTD-indicator injection was calculated.
￿ After correction of GEDVIfem using the correction
formula, GEDVIfem shows high predictive capabil-
ities for GEDVIjug.
￿ For determination of CI and EVLWI accurate
TPTD-data is obtained using femoral access for indi-
cator injection.
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